Payments to Acquire Property, Plant, and Equipment of Protagonist Therapeutics, Inc from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Protagonist Therapeutics, Inc annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Protagonist Therapeutics, Inc Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $545,000, a 125% increase year-over-year.
  • Protagonist Therapeutics, Inc annual Payments to Acquire Property, Plant, and Equipment for 2025 was $1,590,000, a 17% increase from 2024.
  • Protagonist Therapeutics, Inc annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,355,000, a 122% increase from 2023.
  • Protagonist Therapeutics, Inc annual Payments to Acquire Property, Plant, and Equipment for 2023 was $609,000, a 23% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Protagonist Therapeutics, Inc Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,590,000 +$235,000 +17% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $1,355,000 +$746,000 +122% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $609,000 -$186,000 -23% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $795,000 -$306,000 -28% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $1,101,000 +$630,000 +134% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $471,000 -$496,000 -51% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
2019 $967,000 +$481,000 +99% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
2018 $486,000 -$180,000 -27% 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2021 2020 FY
2017 $666,000 +$319,000 +92% 01 Jan 2017 31 Dec 2017 10-K 10 Mar 2020 2019 FY
2016 $347,000 -$52,000 -13% 01 Jan 2016 31 Dec 2016 10-K 12 Mar 2019 2018 FY
2015 $399,000 +$100,000 +33% 01 Jan 2015 31 Dec 2015 10-K 07 Mar 2018 2017 FY
2014 $299,000 01 Jan 2014 31 Dec 2014 10-K 07 Mar 2017 2016 FY

Protagonist Therapeutics, Inc Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $545,000 +$303,000 +125% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $242,000 +$232,000 +2320% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $10,000 -$263,000 -96% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $273,000 +$133,000 +95% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $140,000 +$2,000 +1.4% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $138,000 -$28,000 -17% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q1 2019 $166,000 -$42,000 -20% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $208,000 +$160,000 +333% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $48,000 -$203,000 -81% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q1 2016 $251,000 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.